Barcelona based Flomics Biotech closes seed round of €1.000.000 to develop its multicancer screening solution

by Flomics Biotech SL

Flomics Biotech, a biotech company dedicated to genomics and early screening and diagnosis of complex diseases, such as cancer, announces the closing of a €1.000.000 seed round of investment, led by...

Read more

Flomics Biotech, finalista a los Global Startup Awards

by Flomics Biotech SL

La compañía se ha centrado en el estudio de ARN circulante para la detección precoz de cáncer

Read more

Flomics COVID19 NGS platform update

by Flomics Biotech SL

​Flomics Biotech continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of -FlomicsCOVID19– a cloud-based Next Generation Sequencing (N...

Read more

Flomics ha sido seleccionada para el programa EIT Health Bridgehead

by Flomics Biotech SL

El programa destinado a proyectos del sector de la salud ha seleccionado a 3 startups españolas para Bridgehead Global y a 6 para Bridgehead Europe

Read more

Flomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) and member of the Barcelona Health Hub (BHH)

by Flomics Biotech SL

​Flomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) and member of the Barcelona Health Hub (BHH) was selected among the most disruptive and innovative startups in the Heal...

Read more

Flomics Investment opportunity

by Flomics Biotech SL

Flomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...

Read more

Flomics will present at 'ENRICH in Brazil: COVID-19: International Cooperation in STI in the Health Sector in Brazil and Europe'

by Flomics Biotech SL

The webinar will discuss opportunities for collaboration between Brazil and Europe in the area of Health. Fiocruz (Brazil), Aveiro University (Portugal) and Flomics Biotech (Spain) will discuss how CO...

Read more

Fully automated solution for SARS-CoV-2 NGS-based testing data analysis

by Flomics Biotech SL

Our world is dealing with a global pandemic that threatens life as we know it. The rapidly spreading coronavirus SARS-CoV-2 is a major public health emergency. Worldwide, scientists and healthcare pro...

Read more

Flomics announces a partnership with Lifebit

by Flomics Biotech SL

Flomics is excited to announce a partnership with Lifeb​it in order to deploy an end-to-end cloud solution for COVID19 NGS data analysis. By combining Flomics’ expertise in NGS analysis with the f...

Read more

Flomics COVID-19 NGS platform

by Flomics Biotech SL

Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research.

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream